SpeechVive

SpeechVive, founded in 2011 and based in West Lafayette, Indiana, commercializes a novel wearable device to treat speech impairment (hypophonia) in Parkinson's disease. Its technology leverages a well-established neurobehavioral phenomenon, the Lombard effect, where background noise prompts the brain to automatically increase vocal effort. The company has achieved regulatory clearance, insurance reimbursement, and commercial traction, positioning it as a non-pharmacological, device-based solution in the neurology and digital health space. Currently, the company is navigating a temporary supply chain disruption that has paused new orders.

A wearable, in-ear device that uses the Lombard effect (background noise-triggered reflexive speech) to automatically induce louder and clearer speech in individuals with Parkinson's disease. It includes clinician calibration software for remote personalization.

Primary competition comes from intensive behavioral speech therapy programs, notably Lee Silverman Voice Treatment (LSVT LOUD). Other competitors may include generic voice amplifiers or emerging digital therapeutic apps for speech, but SpeechVive's unique bio-responsive mechanism and insurance coverage create a differentiated position in the market.